Literature DB >> 16271509

Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma.

Fumihiko Tsushima1, Kae Tanaka, Noriko Otsuki, Pornpan Youngnak, Hideyuki Iwai, Ken Omura, Miyuki Azuma.   

Abstract

We examined cell surface expression of five B7 costimulatory molecules (B7-H1, B7-DC, B7h, CD80 and CD86) in human oral squamous cell carcinoma (SCC) lines. Most human SCC cell lines expressed various levels of B7-H1 and B7-DC. Their expression was further upregulated by interferon (IFN)-gamma stimulation. Immunohistochemical staining revealed substantial and predominant expression of B7-H1 on human primary oral SCC. A murine SCC line, NR-S1, neither expressed B7-H1 nor B7-DC, but induced B7-H1 by IFN-gamma stimulation in culture and the inoculation in vivo. Although NR-S1 tumors grew progressively in immunocompetent syngeneic mice, the administration of blocking anti-B7-Hl or anti-PD-1 mAb significantly inhibited the tumor growth, suggesting the negative regulation of host immune responses by the PD-1:B7-H1 pathway. Our results demonstrate that B7-H1 is predominantly induced on oral SCC within the B7 family molecules. A successful inhibition of tumor growth by blockade of the PD-1:B7-H1 pathway may implicate a new approach for immunotherapy of oral SCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271509     DOI: 10.1016/j.oraloncology.2005.07.013

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  33 in total

1.  Pterostilbene protects against acute renal ischemia reperfusion injury and inhibits oxidative stress, inducible nitric oxide synthase expression and inflammation in rats via the Toll-like receptor 4/nuclear factor-κB signaling pathway.

Authors:  Dan Gao; Sanhui Jing; Qian Zhang; Ge Wu
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

Review 2.  The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications.

Authors:  Panagiota Economopoulou; Christos Perisanidis; Evaggelos I Giotakis; Amanda Psyrri
Journal:  Ann Transl Med       Date:  2016-05

Review 3.  Immunoregulatory role of B7-H1 in chronicity of inflammatory responses.

Authors:  Haidong Dong; Xianming Chen
Journal:  Cell Mol Immunol       Date:  2006-06       Impact factor: 11.530

4.  Oral Squamous Carcinoma Cells Express B7-H1 and B7-DC Receptors in Vivo.

Authors:  Sabine Groeger; H P Howaldt; H Raifer; S Gattenloehner; T Chakraborty; J Meyle
Journal:  Pathol Oncol Res       Date:  2016-08-08       Impact factor: 3.201

5.  Expression levels of B7-H3 and TLT-2 in human oral squamous cell carcinoma.

Authors:  Shan-Shan Zhang; Jing Tang; Shu-Yi Yu; L I Ma; Feng Wang; Shu-LE Xie; Long Jin; Hong-Yu Yang
Journal:  Oncol Lett       Date:  2015-05-27       Impact factor: 2.967

6.  Anti-PD-1 synergizes with cyclophosphamide to induce potent anti-tumor vaccine effects through novel mechanisms.

Authors:  Mikayel Mkrtichyan; Yana G Najjar; Estella C Raulfs; Maher Y Abdalla; Raed Samara; Rinat Rotem-Yehudar; Larry Cook; Samir N Khleif
Journal:  Eur J Immunol       Date:  2011-08-17       Impact factor: 5.532

Review 7.  Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer.

Authors:  Charles C L Tong; Johnny Kao; Andrew G Sikora
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 8.  The complex role of B7 molecules in tumor immunology.

Authors:  Barbara Seliger; Francesco M Marincola; Soldano Ferrone; Hinrich Abken
Journal:  Trends Mol Med       Date:  2008-11-03       Impact factor: 11.951

9.  Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity.

Authors:  Juan R Cubillos-Ruiz; Xavier Engle; Uciane K Scarlett; Diana Martinez; Amorette Barber; Raul Elgueta; Li Wang; Yolanda Nesbeth; Yvon Durant; Andrew T Gewirtz; Charles L Sentman; Ross Kedl; Jose R Conejo-Garcia
Journal:  J Clin Invest       Date:  2009-07-13       Impact factor: 14.808

10.  Costimulatory molecule B7-H1 on the immune escape of bladder cancer and its clinical significance.

Authors:  Yonghua Wang; Qianyuan Zhuang; Siwei Zhou; Zhiquan Hu; Ruzhu Lan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.